Guilin sanjin drug co., ltd. technology research and development

Technology Center: It is the technical management and new product research and development institution of Sanjin Pharmaceutical. After several years of development and improvement, Sanjin Pharmaceutical Technology Center has become a modern enterprise technology center with complete functional supporting system, reasonable structure and advanced facilities, including two platforms for new drug development and industrialization research and related functional management departments. Under the direct leadership of the person in charge of the enterprise, the Technology Center has developed two Chinese medicine brands, namely, three gold medals series and three gold tablets series in watermelon frost. Watermelon frost series products are listed as protected varieties by AQSIQ. 200165438+February, Sanjin Pharmaceutical Technology Center was officially recognized as a national enterprise technology center after strict qualification examination by the State Economic and Trade Commission and the Enterprise Technology Evaluation Center of Chinese Academy of Sciences. In the same year, the enterprise postdoctoral research center was established with the approval of the Ministry of Personnel. The technical center consists of three functional institutions: the central office, the production technology department and the drug research institute.

Drug Research Institute: It consists of drug screening research center, natural drug research center, modern Chinese medicine new drug research center and preparation research center. Multidisciplinary personnel, complete professional categories, strong technical force, rich experience in technological innovation and strong development ability.

The role of the Institute of Pharmacology is: 1. Modern Chinese medicine with independent intellectual property rights is developed by applying modern technical means, combining traditional Chinese medicine theory and based on Chinese herbal medicine resources in Guangxi. 2. The second innovation of the company's old products. The technical content and market competitiveness of old products can be improved through the re-study on the improvement of technology and quality standards of old products. 3. Conduct basic research on listed varieties to provide technical support for the market. 4. Committed to the extraction, separation, qualitative and quantitative analysis of effective components of traditional Chinese medicine, and developed natural medicines with independent intellectual property rights. 5, to carry out research on new technologies and new dosage forms. 6, to carry out drug screening, provide experimental basis for new drug development, and point out the direction for new drug research. 7. Carry out research on the resources of traditional Chinese medicine with Guangxi characteristics, and guide the construction of GAP base.

The new scientific research building with an investment of 35 million yuan can be engaged in the research of tablets, capsules, powders, pills, granules, dripping pills, suppositories, injections, soft capsules and other preparations; Supercritical extraction, macroporous resin separation, membrane separation, freeze-drying, ultrasonic extraction, ultra-micro (airflow) pulverization and other technologies; Advanced detection instruments include: WATERS HPLC, SP HPLC, HP and PE GC, Kama SCANNER3 thin-layer scanner, PE atomic absorption spectrophotometer, etc.

In order to gain long-term competitive advantage, the company has determined the medium and long-term planning and development strategy of the enterprise. The medium and long-term plan is: to establish a leading domestic and international first-class production enterprise focusing on traditional Chinese medicine and natural medicine; The development strategy is: adhere to the guidance of traditional Chinese medicine theory, take modern science and technology as a means, and rely on Guangxi's rich Chinese herbal medicine and Zhuang medicine resources to develop modern Chinese patent medicines with independent intellectual property rights, which are safe and effective, controllable in quality and blank or scarce in the market. On the basis of medium-and long-term planning of the enterprise, the innovative development plan combining science and technology with economy has been formulated, forming a "three-gold" and "four-dimensional" technology development strategy, and the research and development of new products has formed a virtuous circle of "producing a batch, storing a batch, developing a batch and conceiving a batch"; The development of old products has formed a pattern of "producing one generation, taking one generation, researching one generation and thinking about one generation"; Production development shows the trend of "sowing a batch of seeds, selecting a batch of seedlings and raising a batch of wood", and technological development forms a multi-level structure combining traditional technology, general technology and advanced high technology. According to the current situation at home and abroad and the enterprise's own situation, the Technology Center constantly improves the enterprise's technological innovation strategy, and puts forward that the technological innovation strategy takes the research and development of traditional Chinese medicine and natural medicine as the main direction of technological innovation, biomedicine, functional health food and daily chemical products as the auxiliary innovation direction, and takes the technology center as the platform, from basic technology and technology to product innovation, so as to continuously improve the originality and scientific and technological content of the enterprise and finally improve the core competitiveness of the enterprise.